MedPath

NovoMix 30 FlexPen

Brand Name: NovoMix 30 FlexPen

Generic Name: Biphasic Insulin Aspart 30

Active
Registration Number

BR-1014

Dosage Form

Suspension for injection (SC)

Issuance Date

February 1, 2022

Expiry Date

December 21, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 IU/ mL
PackagingPre-filled pen x 3mL composed of injector and pre-filled cartridge (5pens/box)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antidiabetic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Biphasic Insulin Aspart 30Active
Monograph: Insulin aspart

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform